<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xml:lang="hr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">LV</journal-id>
<journal-id journal-id-type="nlm-ta">Lijec Vjesn</journal-id>
<journal-title-group>
<journal-title>Lijecnicki Vjesnik</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Lijec. Vjesn.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0024-3477</issn>
<issn pub-type="epub">1849-2177</issn>
<publisher><publisher-name>Croatian Medical Association</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">LV-145-252</article-id>
<article-id pub-id-type="doi">10.26800/LV-145-7-8-3</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Drugs and procedures</subject></subj-group>
</article-categories>
<title-group>
<article-title>Respiracijski monitoring je preduvjet za sigurnu primjenu neinvazivne ventilacije</article-title>
<trans-title-group xml:lang="en">
<trans-title>Respiratory monitoring is a prerequisite for safe noninvasive ventilation</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kopi&#x0107;</surname><given-names>Jasminka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jurjevi&#x0107;</surname><given-names>Matija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mirkovi&#x0107;</surname><given-names>Ivan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mrzljak Vu&#x010D;ini&#x0107;</surname><given-names>Natalija</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<aff id="aff1"><label>1</label>Odjel za anesteziju, reanimaciju i intenzivnu medicinu, Op&#x0107;a bolnica &#x201E;Dr. Josip Ben&#x010D;evi&#x0107;&#x201C;, Slavonski Brod</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Adresa za dopisivanje: Doc. dr. sc. Jasminka Kopi&#x0107;, dr. med., Odjel za anesteziju, reanimaciju i intenzivnu medicinu, Op&#x0107;a bolnica &#x201E;Dr. Josip Ben&#x010D;evi&#x0107;&#x201C;, Andrije &#x0160;tampara 42, 35000 Slavonski Brod, e-po&#x0161;ta: <email xlink:href="jasminka.kopic@bolnicasb.hr">jasminka.kopic@bolnicasb.hr</email></corresp>
<fn fn-type="con">
<p content-type="fn-title">DOPRINOS AUTORA</p>
<p>K<sc>oncepcija</sc> <sc>ili</sc> <sc>nacrt</sc> <sc>rada</sc>: JK, MJ, IM, NMV</p>
<p>P<sc>rikupljanje</sc>, <sc>analiza</sc> <sc>i</sc> <sc>interpretacija</sc> <sc>podataka</sc>: JK</p>
<p>P<sc>isanje</sc> <sc>prve</sc> <sc>verzije</sc> <sc>rada</sc>: JK</p>
<p>K<sc>riti&#x010D;ka</sc> <sc>revizija</sc>: MJ, IM, NMV</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub"><month>07</month><year>2023</year></pub-date>
<volume>145</volume>
<issue>7-8</issue>
<fpage>252</fpage>
<lpage>256</lpage>
<permissions>
<copyright-statement>Croatian Medical Association</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Croatian Medical Association</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" specific-use="CC BY-NC-ND 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.</license-p></license>
</permissions>
<abstract>
<title>SA&#x017D;ETAK</title>
<p>Neinvazivna ventilacija (NIV) je u&#x010D;inkovit na&#x010D;in respiracijske potpore za dio bolesnika sa zatajenjem disanja. Pravovremenom primjenom NIV-a kod dijela bolesnika mo&#x017E;e se izbje&#x0107;i invazivna ventilacija i njezini ne&#x017E;eljeni u&#x010D;inci, &#x010D;ime se skra&#x0107;uje vrijeme provedeno u Jedinici intenzivnog lije&#x010D;enja (JIL). U zadnjih dvadeset godina bilje&#x017E;i se u&#x010D;estalija primjena NIV-a, a pove&#x0107;ava se i broj indikacija kod kojih se NIV pokazao kao metoda izbora. Tijekom pandemije COVID-19 NIV je postao vrlo popularan i kod bolesnika sa zatajenjem disanja u sklopu infekcije COVID-19 primjenjivan je diljem svijeta. Cilj rada je istaknuti nu&#x017E;nost respiracijskog nadzora za sigurnu primjenu NIV-a te upozoriti klini&#x010D;are koji primjenjuju NIV u svakodnevnom radu na va&#x017E;nost uo&#x010D;avanja ubrzanog disanja i velikoga inspiracijskog napora kao klini&#x010D;kih pokazatelja velikoga di&#x0161;noga rada. Neovisno o primarnom uzroku plu&#x0107;noga o&#x0161;te&#x0107;enja, veliki di&#x0161;ni rad dodatno pogor&#x0161;ava zatajenje disanja putem &#x201E;samoozlje&#x0111;ivanja&#x201C; plu&#x0107;a (engl. <italic>patient self inflicted lung injury</italic>, P-SILI). Istaknuti su pokazatelji respiracijskog nadzora koji neizravno ukazuju na opasnost od P-SILI, a to su: veliki volumeni udisaja (engl. <italic>tidal volume</italic>, VT), negativni pomaci na krivulji alveolarnoga tlaka (engl. <italic>alveolar pressure</italic>, Paw), pove&#x0107;ane vrijednosti okluzijskog tlaka u di&#x0161;nome putu (P0.1) te visoke vrijednosti <italic>&#x201E;driving&#x201C;</italic> tlaka. Smanjenje i kontroliranje velikoga di&#x0161;noga rada izazov je u svim situacijama u kojima bolesnik spontano di&#x0161;e, neovisno je li na neinvazivnoj ili invazivnoj potpori disanja. Temeljem do sada objavljenih spoznaja, kao i iz osobnih iskustava ste&#x010D;enih dugogodi&#x0161;njom primjenom NIV-a u razli&#x010D;itim klini&#x010D;kim indikacijama, nastojali smo sa&#x017E;eti mogu&#x0107;e na&#x010D;ine kontrole pove&#x0107;anoga di&#x0161;nog rada. Samo striktnim nadzorom respiracijskih pokazatelja, kontrolom pove&#x0107;anoga di&#x0161;nog rada i poznavanjem NIV-a kao metode potpore disanja njegova primjena postaje sigurna, a eventualni neuspjeh NIV-a i potreba za prijelazom na invazivnu ventilaciju bit &#x0107;e na vrijeme prepoznata.</p>
</abstract>
<trans-abstract xml:lang="en">
<title>SUMMARY</title>
<p>Noninvasive ventilation (NIV) is an effective respiratory support for some patients with respiratory failure. Timely NIV application can help some patients avoid invasive mechanical ventilation (IMV) and its adverse effects, and thus shorten their length of stay in the ICU. NIV use became more frequent during the last 20 years and has been proven as a method of choice for a number of indications. NIV became very popular during the COVID-19 pandemic and was used all over the world. Main goals of this paper are to emphasize respiratory monitoring as a prerequisite for safe NIV application and to warn clinicians of the importance of high respiratory rate and huge inspiratory effort as clinical signs of high work of breathing (WOB). Regardless of the primary cause of lung injury, high WOB further impairs respiratory failure by self-inflicted lung injury (P-SILI). Indirect signs of high WOB, such as high tidal volume (VT), negative swings on airway pressure curve (Paw), high airway occlusion pressure (P0.1) and high driving pressure are discussed as predictors of P-SILI. High WOB attenuation and its control is challenging in all spontaneously breathing patients, whether their respiratory support is invasive or noninvasive. Based on published knowledge and our own experience during long lasting NIV use in different clinical situations, we tried to point out options for high WOB control. NIV is safe only under conditions of strict respiratory monitoring, high WOB control and good knowledge of NIV as a method of respiratory support. In such cases NIV failure will be recognized and a switch to IMV will be performed on time.</p>
</trans-abstract>
<kwd-group kwd-group-type="author"><kwd>Deskriptori MEHANI&#x010C;KA VENTILACIJA &#x2013; metode</kwd><kwd>NEINVAZIVNA VENTILACIJA &#x2013; ne&#x017E;eljeni u&#x010D;inci</kwd><kwd>O&#x0160;TE&#x0106;ENJE PLU&#x0106;A &#x2013; prevencija</kwd><kwd>FIZIOLO&#x0160;KO PRA&#x0106;ENJE &#x2013; metode</kwd><kwd>MEHANIKA DISANJA &#x2013; fiziologija</kwd><kwd>RESPIRACIJSKA INSUFICIJENCIJA &#x2013; etiologija, lije&#x010D;enje</kwd><kwd>COVID-19 &#x2013; lije&#x010D;enje</kwd><kwd>JEDINICE INTENZIVNOG LIJE&#x010C;ENJA</kwd></kwd-group>
<kwd-group kwd-group-type="translator" xml:lang="en"><title>Descriptors </title><kwd>RESPIRATION, ARTIFICIAL &#x2013; methods</kwd><kwd>NONINVASIVE VENTILATION &#x2013; adverse effects</kwd><kwd>LUNG INJURY &#x2013; prevention and control</kwd><kwd>FIZIOLO&#x0160;KO PRA&#x0106;ENJE &#x2013; metode</kwd><kwd>RESPIRATORY MECHANICS &#x2013; physiology</kwd><kwd>WORK OF BREATHING</kwd><kwd>RESPIRATORY INSUFFICIENCY &#x2013; etiology, therapy</kwd><kwd>COVID-19 &#x2013; therapy</kwd><kwd>INTENSIVE CARE UNITS</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Neinvazivna ventilacija je na&#x010D;in potpore disanja putem intaktnoga di&#x0161;nog puta bolesnika uz pomo&#x0107; razli&#x010D;itih poveznica spojenih na respirator. Te poveznice mogu biti: maska preko bolesnikova nosa, maska preko bolesnikovih usta i nosa, maska preko &#x010D;itavoga lica bolesnika ili kaciga (engl. <italic>helmet</italic>). Prve primjene i razvoj NIV-a zabilje&#x017E;eni su 1940-ih godina u podru&#x010D;ju avijacije, a njezina klini&#x010D;ka primjena kao i definiranje mjesta u lije&#x010D;enju bolesnika sa zatajenjem disanja bilje&#x017E;i se od 1980-ih godina. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>-<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) Pravovremenom primjenom NIV-a kod dijela bolesnika sa zatajenjem disanja mo&#x017E;emo sprije&#x010D;iti potrebu za invazivnom mehani&#x010D;kom ventilacijom i na taj na&#x010D;in sprije&#x010D;iti pridru&#x017E;ene komplikacije, kao &#x0161;to su potreba za sedacijom i ventilator-pridru&#x017E;ena pneumonija, te tako zna&#x010D;ajno skratiti vrijeme provedeno u jedinici intenzivnog lije&#x010D;enja. (<xref ref-type="bibr" rid="r4"><italic>4</italic></xref>)</p>
<p>Za postizanje pune u&#x010D;inkovitosti NIV-a kao na&#x010D;ina potpore disanja neophodno je dobro poznavanje njegovih indikacija, tj. odabir prikladnog bolesnika, nadzor &#x017E;ivotnih funkcija uklju&#x010D;iv&#x0161;i respiracijski nadzor i, &#x0161;to je najbitnije, pravovremeno prepoznavanje eventualne neu&#x010D;inkovitosti NIV-a i stoga prelazak na invazivnu strojnu ventilaciju. NIV je metoda izbora potpore disanja u: akutizaciji zatajenja disanja kod kroni&#x010D;ne opstruktivne bolesti plu&#x0107;a (KOPB), (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>) akutnome plu&#x0107;nom edemu u sklopu sr&#x010D;anog popu&#x0161;tanja, (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>) zatajenju disanja u sklopu pneumonije kod imunokompromitiranih bolesnika, (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>) zatajenju disanja kod razli&#x010D;itih neurolo&#x0161;kih stanja poput multiple skleroze, amiotrofi&#x010D;ne lateralne skleroze i mi&#x0161;i&#x0107;ne distrofije, (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>) zatajenju disanja kod ozljeda grudnoga ko&#x0161;a (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>) te u procesu odvajanja od respiratora nakon dugotrajne strojne ventilacije. (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>) Nasuprot tomu, primjena NIV-a u hipoksemijskom zatajenju disanja tipa akutnoga respiracijskog distres sindroma (ARDS) je upitna, a njegova u&#x010D;inkovitost je ovisna o nizu &#x010D;imbenika, od kojih je najva&#x017E;nije vrijeme primjene. Studija <italic>Lung Safe</italic> koja je ra&#x0111;ena na skupini od 2.813 bolesnika s ARDS-om pokazala je da je NIV primijenjen kod 15,5% bolesnika te da je u&#x010D;inkovitost NIV-a bila najlo&#x0161;ija u skupini bolesnika s te&#x0161;kim ARDS-om gdje je zabilje&#x017E;en neuspjeh NIV-a kod 47% bolesnika. (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>)</p>
<p>Europska anketa o primjeni neinvazivne ventilacije, provedena me&#x0111;u 530 lije&#x010D;nika, pokazala je veliku razli&#x010D;itost u primjeni NIV-a u svakodnevnoj praksi, ali i zna&#x010D;ajan porast njegove primjene zadnjih dvadesetak godina. (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) Osobito brzi porast primjene NIV-a dogodio se tijekom pandemije COVID-19, poglavito zbog potrebe za &#x0161;to kra&#x0107;im trajanjem potpore disanja i nedostatka respiratora u pojedinim razdobljima velikog priljeva bolesnika, ali i zbog naravi bolesti kod koje je kod ve&#x0107;ine bolesnika sa zatajenjem disanja funkcija drugih organskih sustava bila o&#x010D;uvana, uklju&#x010D;uju&#x0107;i o&#x010D;uvanu mentalnu funkciju.</p>
<p>Tako se iz <italic>ISARIC Clinical Data Reporta</italic> od o&#x017E;ujka 2022., koji se odnosi na 109.599 bolesnika oboljelih od COVID-19 sa zatajenjem disanja, vidi da je kod 47,1% bolesnika diljem svijeta primijenjen neki od neinvazivnih na&#x010D;ina potpore disanja, dok je 61,3% bolesnika bilo na invazivnoj strojnoj ventilaciji. (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>)</p>
<sec sec-type="other1">
<title>Za&#x0161;to je bolesniku na NIV-u neophodan respiracijski nadzor</title>
<p>Zbog jednostavnijeg postavljanja (o&#x010D;uvan di&#x0161;ni put bolesnika) i sve &#x0161;ire upotrebe (jedinice intenzivne medicine, odjeli hitnoga prijama, kardiolo&#x0161;ki, pulmolo&#x0161;ki odjeli, izvanbolni&#x010D;ko zbrinjavanje, ku&#x0107;na ventilacija), uvrije&#x017E;ena je zabluda da je NIV &#x201E;jednostavniji&#x201C; i manje zahtjevan od invazivne strojne ventilacije. Me&#x0111;utim, za procjenu u&#x010D;inkovitosti NIV-a i pravovremeno uo&#x010D;avanje potrebe za prelaskom na invazivnu strojnu ventilaciju neophodan je sveobuhvatan respiracijski nadzor, za &#x0161;to su dobar monitoring i znanje od klju&#x010D;ne va&#x017E;nosti.</p>
<p>Cilj ovoga rada jest ukazati na va&#x017E;nost prepoznavanja &#x201E;samoozlje&#x0111;ivanja&#x201C; plu&#x0107;a izazvanog pove&#x0107;anim di&#x0161;nim radom, &#x0161;to je &#x010D;est mehanizam pogor&#x0161;anja zatajenja disanja neovisno o primarnoj bolesti plu&#x0107;a. (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>) Znakovi velikoga di&#x0161;nog rada koje mo&#x017E;emo uo&#x010D;iti pokraj kreveta bolesnika, a koji ukazuju na P-SILI, jesu pove&#x0107;ana frekvencija disanja i velik inspiracijski napor. Napominjemo da je opasnost velikoga di&#x0161;nog rada jednako prisutna kod svih bolesnika koji spontano di&#x0161;u, neovisno jesu li na NIV-u ili na invazivnoj strojnoj ventilaciji.</p>
<p>Na&#x010D;in na koji veliki inspiracijski napor dodatno o&#x0161;te&#x0107;uje plu&#x0107;a jest njime izazvano pove&#x0107;anje transpulmonalnoga tlaka, koji s posljedi&#x010D;nim upuhivanjem velikih disajnih volumena u slabo prozra&#x010D;ena podru&#x010D;ja plu&#x0107;a izaziva volutraumu i barotraumu. (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>, <xref ref-type="bibr" rid="r15"><italic>15</italic></xref>) Osim toga, velike negativizacije tlaka u pleuralnom prostoru izazvane sna&#x017E;nom aktivno&#x0161;&#x0107;u respiracijskih mi&#x0161;i&#x0107;a u inspiriju pove&#x0107;avaju transmuralni tlak u plu&#x0107;nim krvnim &#x017E;ilama i na taj na&#x010D;in izazivaju plu&#x0107;ni edem, &#x0161;to dalje pogor&#x0161;ava funkciju disanja.</p>
<p>Zlatni standard za mjerenje inspiracijskog napora jest mjerenje ezofagealnog tlaka (engl. <italic>oesophageal pressure</italic>, Pes) (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>), no budu&#x0107;i da mjerenje Pes-a zahtijeva postavljanje ezofagealnog katetera ono se za sada ne radi rutinski. Neizravni pokazatelji pove&#x0107;anoga inspiracijskog napora, a koji su dio standardnoga respiracijskog monitoringa pa ih mo&#x017E;emo uo&#x010D;iti kraj kreveta bolesnika jesu:</p>
<list id="L1" list-type="order"><list-item><p>veliki di&#x0161;ni volumen kod spontanog disanja (<xref ref-type="fig" rid="f1">Figure 1</xref>)</p></list-item>
<list-item><p>veliki negativni pomaci na krivulji alveolarnog tlaka (<xref ref-type="fig" rid="f1">Figure 1</xref>)</p></list-item>
<list-item><p>visoke vrijednosti P0.1 (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>) (tlak u zatvorenome di&#x0161;nom putu u prvih 100 milisekundi udisaja) (<xref ref-type="fig" rid="f2">Figure 2</xref>)</p></list-item>
<list-item><p>visoki &#x201E;<italic>driving</italic>&#x201C; tlak, tj. razlika izme&#x0111;u tlaka platoa (<italic>Pplato</italic>) dobivenog endinspiracijskim zadr&#x017E;avanjem daha i ukupnog tlaka u end-ekspiriju, a koji je zbroj zadanog tlaka u ekspiriju (engl. <italic>positive end-expiratory pressure</italic>, PEEP) i intrinzi&#x010D;kog ili auto PEEP-a (PEEPi).</p></list-item></list>
<fig id="f1" position="float" fig-type="figure"><label>Figure 1</label><caption><p>High tidal volume and high negative swings on the alveolar pressure curve (Paw) in spontaneously breathing patient</p></caption><graphic xlink:href="LV-145-252-f1"></graphic></fig>
<fig id="f2" position="float" fig-type="figure"><label>Figure 2</label><caption><p>Airway occlusion pressure (P0.1)</p></caption><graphic xlink:href="LV-145-252-f2"></graphic></fig>
</sec>
<sec sec-type="other2">
<title>Kako kontrolirati veliki di&#x0161;ni rad kod bolesnika koji spontano di&#x0161;e</title>
<p>Veliki inspiracijski napor rezultira ve&#x0107;im volumenom udisaja, &#x0161;to se osobito vi&#x0111;a kod bolesnika s izra&#x017E;enom &#x201E;gladi&#x201C; za zrakom u sklopu hipoksemijskog zatajenja disanja. Tek postavljanjem na NIV kod takvih se bolesnika objektivizira koliko je zaista njihov VT velik. Tako smo &#x010D;esto kod bolesnika sa zatajenjem disanja u sklopu COVID-19 vidjeli ekstremno visoke VT, &#x010D;ak od 1 do 2 L, &#x0161;to za prosje&#x010D;nog bolesnika zna&#x010D;i 15 &#x2013; 25 ml/kg ITM (idealne tjelesne mase).</p>
<p>Pri odabiru modaliteta disanja potrebno je imati na umu da bismo dodavanjem tla&#x010D;ne potpore (engl. <italic>pressure support</italic>, PS) dodatno pove&#x0107;ali &#x201E;<italic>driving</italic>&#x201C; tlak i VT. Stoga je takvim bolesnicima, ako ostanu na spontanom disanju, &#x0161;tetno dodavati tla&#x010D;nu potporu, ve&#x0107; ih je bolje ostaviti na disanju s trajno pozitivnim tlakom u di&#x0161;nome putu (engl. <italic>continuous positive airway pressure</italic>, CPAP).</p>
<p>Bitno je spomenuti da se tlakovi u respiracijskom krugu zbrajaju, a to su: tlak proizveden mi&#x0161;i&#x0107;nim radom (engl. <italic>muscle pressure</italic>, Pmus), PEEP, PEEPi i PS, ako smo ga zadali. Kod bolesnika koji spontano di&#x0161;u, postupkom zadr&#x017E;avanja daha na kraju udisaja mo&#x017E;emo izmjeriti Pplato, gdje &#x0107;e o&#x010D;itani Pplato biti zbroj svih naprijed navedenih tlakova, tako da iz razlike o&#x010D;itanog Pplato-a i zadanog PEEP-a dobivamo vrijednost &#x201E;<italic>driving</italic>&#x201C; tlaka (<xref ref-type="fig" rid="f3">Figure 3</xref>). (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>) Dobro je poznato da su ve&#x0107;e vrijednosti &#x201E;<italic>driving</italic>&#x201C; tlaka povezane s ve&#x0107;om smrtnosti i da je &#x201E;<italic>driving</italic>&#x201C; tlak ve&#x0107;i od 15 cm H<sub>2</sub>O glavni &#x010D;imbenik plu&#x0107;ne ozljede, bilo da je njegova vrijednost rezultat ekscesivnoga inspiracijskog napora kod bolesnika koji spontano di&#x0161;u ili visokih tlakova ventilacije kod bolesnika na kontroliranoj ventilaciji. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>)</p>
<fig id="f3" position="float" fig-type="figure"><label>Figure 3</label><caption><p>End-inspiratory hold manoeuvre and Pplato (plato pressure) in spontaneously breathing patient</p></caption><graphic xlink:href="LV-145-252-f3"></graphic></fig>
<p>Moderni respiratori automatski o&#x010D;itavaju tlak u prvih 100 ms inspirija u zatvorenome di&#x0161;nom krugu (P0.1), ali da bi se P0.1 o&#x010D;itavao treba postaviti tla&#x010D;ni okida&#x010D; udisaja (&#x201E;<italic>trigger</italic>&#x201C; inspirija). Njegova vrijednost korelira sa snagom inspirija pa je tako u nekim situacijama (npr. kod bolesnika s akutizacijom KOPB-a) koristan u procjeni spremnosti bolesnika za odvajanje od respiratora, dok kod bolesnika s velikom &#x201E;gladi&#x201C; za zrakom dobro korelira s Pes-om i koristan je pokazatelj inspiracijskog napora, kao i opasnosti od P-SILI. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>)</p>
<p>Vi&#x0161;e je na&#x010D;ina da smanjimo bolesnikovu &#x201E;glad&#x201C; za zrakom i rad disanja, a naj&#x010D;e&#x0161;&#x0107;e tek kombiniranjem i zbrajanjem pozitivnih u&#x010D;inaka vi&#x0161;e njih posti&#x017E;emo vidljiv klini&#x010D;ki napredak. Prvenstveno je potrebno osigurati dobru ventilaciju, a za to je neophodan &#x201E;<italic>recruitment</italic>&#x201C; plu&#x0107;a, koji &#x0107;emo kod bolesnika na spontanom disanju posti&#x0107;i odabirom adekvatnoga PEEP-a. Morais i suradnici su pokazali da je kod bolesnika s ARDS-om koji spontano di&#x0161;u podizanje PEEP-a od 5 cm H<sub>2</sub>O na 15 cm H<sub>2</sub>O rezultiralo smanjenjem negativnih pomaka Pes-a za oko 50%, &#x0161;to je zna&#x010D;ilo isto toliko smanjenje inspiracijskog napora. Iz navedenih rezultata zaklju&#x010D;ili su da adekvatan PEEP odr&#x017E;avanjem otvorenih plu&#x0107;a rezultira: smanjenjem atelektotraume, pove&#x0107;anjem funkcionalnoga rezidualnog kapaciteta (FRC), smanjenjem edema u plu&#x0107;nome tkivu, &#x0161;to sve smanjuje P-SILI. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>)</p>
<p>Osim dobro odabranog PEEP-a, sljede&#x0107;e &#x0161;to mo&#x017E;e smanjiti P-SILI jest bolja uskla&#x0111;enost ventilacije i perfuzije plu&#x0107;a, a za &#x0161;to se pokazalo da je kod bolesnika s ARDS-om (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>) i kod bolesnika sa zatajenjem disanja uslijed bolesti COVID-19 od velike koristi potrbu&#x0161;ni polo&#x017E;aj. (<xref ref-type="bibr" rid="r22"><italic>22</italic></xref>)</p>
<p>Za osiguravanje dobre ventilacije neophodna je i dobra sinkronizacija bolesnika i respiratora, &#x0161;to &#x0107;emo posti&#x0107;i ispravnim odabirom inspiracijskog i ekspiracijskog okida&#x010D;a. (<xref ref-type="bibr" rid="r23"><italic>23</italic></xref>)</p>
<p>&#x0160;to se ti&#x010D;e kontrole frekvencije disanja, od presudnog je zna&#x010D;enja umiriti bolesnika razgovorom i obja&#x0161;njenjem situacije, ako je potrebno i sedirati ga, smanjiti povi&#x0161;enu tjelesnu temperaturu i svakako djelovati na etiolo&#x0161;ke &#x010D;imbenike zatajenja disanja, tj. lije&#x010D;enje osnovne bolesti.</p>
</sec>
<sec sec-type="other3">
<title>Zaklju&#x010D;ak</title>
<p>Ovaj smo &#x010D;lanak namijenili svim lije&#x010D;nicima koji primjenjuju NIV u svakodnevnoj klini&#x010D;koj praksi. Cilj nam je bio ukazati na osnovne zna&#x010D;ajke mehanike ventilacije kod bolesnika koji di&#x0161;u spontano, kao i na kori&#x0161;tenje jednostavnih pokazatelja koji su standardni dio respiracijskog nadzora svakoga modernog respiratora, s ciljem prepoznavanja velikog rada disanja. Tako&#x0111;er smo nastojali ukazati na mogu&#x0107;e na&#x010D;ine kontrole rada disanja, usmjerene na smanjenje P-SILI i sprje&#x010D;avanje daljnjeg pogor&#x0161;anja respiracijske funkcije.</p>
<p>Dobra mehanika disanja glavni je preduvjet dobre respiracijske funkcije, tj. adekvatne izmjene plinova. Stoga je glavni zadatak svake potpore disanja osigurati dobru mehaniku disanja uz &#x0161;to manju ozljedu plu&#x0107;a. Naravno da je uz nadzor mehanike disanja potrebno nadzirati i pokazatelje respiracijske funkcije, tj. izmjene plinova. Pokazatelji koje rutinski nadziremo jesu PaO<sub>2</sub> (parcijalni tlak kisika u arterijskoj krvi), PaCO<sub>2</sub> (parcijalni tlak uglji&#x010D;nog dioksida u arterijskoj krvi), koncentracija uglji&#x010D;nog dioksida u izdahnutom zraku (engl. <italic>end tidal</italic> CO<sub>2</sub>, ETCO<sub>2</sub>) i SpO<sub>2</sub> (zasi&#x0107;enost periferne krvi kisikom mjerena pulsnom oksimetrijom). Va&#x017E;no je imati na umu da su pokazatelji oksigenacije, i PaO<sub>2</sub> i SpO<sub>2</sub> podlo&#x017E;ni promjenama ovisno o zadanoj koncentraciji kisika, a da je ETCO<sub>2</sub> ovisan kako o ventilacijskoj funkciji tako i o prokrvljenosti plu&#x0107;a. Stoga samo sveobuhvatan nadzor koji uklju&#x010D;uje i respiracijske i hemodinamske pokazatelje, kao i razlo&#x017E;no klini&#x010D;ko promi&#x0161;ljanje, mo&#x017E;e rezultirati sigurnom potporom disanja.</p>
<p>Nadamo se da &#x0107;e redovito pra&#x0107;enje u &#x010D;lanku navedenih respiracijskih pokazatelja, dostupnih kraj kreveta bolesnika, pomo&#x0107;i u&#x010D;inkovitijoj i sigurnijoj primjeni NIV-a.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p content-type="fn-title">INFORMACIJE O SUKOBU INTERESA</p>
<p>Autori nisu deklarirali sukob interesa relevantan za ovaj rad.</p>
</fn>
<fn fn-type="financial-disclosure">
<p content-type="fn-title">INFORMACIJA O FINANCIRANJU</p>
<p>Za ovaj &#x010D;lanak nisu primljena financijska sredstva.</p>
</fn>
</fn-group>
<ref-list>
<title>LITERATURA</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motley</surname><given-names>HL</given-names></name><name><surname>Werko</surname><given-names>L</given-names></name><name><surname>Cournand</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>DW</given-names></name></person-group>. <article-title>Observations on the clinical use of intermittent positive pressure.</article-title> <source>J Aviat Med</source>. <year>1947</year>;<volume>18</volume>:<fpage>417</fpage>&#x2013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">18899916</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>DJ</given-names></name></person-group>. <article-title>History and epidemiology of noninvasive ventilation in the acute-care setting.</article-title> <source>Respir Care</source>. <year>2009</year>;<volume>54</volume>:<fpage>40</fpage>&#x2013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">19111105</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meduri</surname><given-names>GU</given-names></name><name><surname>Conoscenti</surname><given-names>CC</given-names></name><name><surname>Menashe</surname><given-names>P</given-names></name><name><surname>Nair</surname><given-names>S</given-names></name></person-group>. <article-title>Noninvasive face mask ventilation in patients with acute respiratory failure.</article-title> <source>Chest</source>. <year>1989</year>;<volume>95</volume>:<fpage>865</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1378/chest.95.4.865</pub-id><pub-id pub-id-type="pmid">2924616</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochard</surname><given-names>L</given-names></name></person-group>. <article-title>Mechanical ventilation: invasive versus noninvasive.</article-title> <source>Eur Respir J</source>. <year>2003</year>;<volume>47</volume>:<fpage>31s</fpage>&#x2013;<lpage>7s</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.03.00050403</pub-id><pub-id pub-id-type="pmid">14621115</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lightowler</surname><given-names>JV</given-names></name><name><surname>Wedzicha</surname><given-names>JA</given-names></name><name><surname>Elliot</surname><given-names>MW</given-names></name><name><surname>Ram</surname><given-names>FS</given-names></name></person-group>. <article-title>Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis.</article-title> <source>BMJ</source>. <year>2003</year>;<volume>326</volume>:<fpage>185</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.326.7382.185</pub-id><pub-id pub-id-type="pmid">12543832</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Goodacre</surname><given-names>S</given-names></name><name><surname>Newby</surname><given-names>DE</given-names></name><name><surname>Masson</surname><given-names>M</given-names></name><name><surname>Sampson</surname><given-names>F</given-names></name><name><surname>Nicholl</surname><given-names>J</given-names></name></person-group>. <article-title>Noninvasive ventilation in acute cardiogenic pulmonary edema.</article-title> <source>N Engl J Med</source>. <year>2008</year>;<volume>359</volume>(<issue>2</issue>):<fpage>142</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0707992</pub-id><pub-id pub-id-type="pmid">18614781</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregg</surname><given-names>RW</given-names></name><name><surname>Friedman</surname><given-names>BC</given-names></name><name><surname>Williams</surname><given-names>JF</given-names></name><name><surname>McGrath</surname><given-names>BJ</given-names></name><name><surname>Zimmerman</surname><given-names>JE</given-names></name></person-group>. <article-title>Continuous positive airway pressure by face mask in Pneumocystis carinii pneumonia.</article-title> <source>Crit Care Med</source>. <year>1990</year>;<volume>18</volume>:<fpage>21</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1097/00003246-199001000-00006</pub-id><pub-id pub-id-type="pmid">2403506</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>JR</given-names></name><name><surname>Alba</surname><given-names>AS</given-names></name><name><surname>Saporito</surname><given-names>LR</given-names></name></person-group>. <article-title>Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users.</article-title> <source>Chest</source>. <year>1993</year>;<volume>103</volume>:<fpage>174</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1378/chest.103.1.174</pub-id><pub-id pub-id-type="pmid">8417874</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolliger</surname><given-names>CT</given-names></name><name><surname>Van Eeden</surname><given-names>SF</given-names></name></person-group>. <article-title>Treatment of multiple rib fractures. Randomized controlled trial comparing ventilatory with nonventilatory management.</article-title> <source>Chest</source>. <year>1990</year>;<volume>97</volume>:<fpage>943</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1378/chest.97.4.943</pub-id><pub-id pub-id-type="pmid">2182301</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>M</given-names></name><name><surname>Valencia</surname><given-names>M</given-names></name><name><surname>Nicolas</surname><given-names>JM</given-names></name><name><surname>Bernadich</surname><given-names>O</given-names></name><name><surname>Badia</surname><given-names>JR</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name></person-group>. <article-title>Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial.</article-title> <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>173</volume>:<fpage>164</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200505-718OC</pub-id><pub-id pub-id-type="pmid">16224108</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Pham</surname><given-names>T</given-names></name><name><surname>Madotto</surname><given-names>F</given-names></name><name><surname>Fan</surname><given-names>E</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE Study.</article-title> <source>Am J Respir Crit Care Med</source>. <year>2017</year>;<volume>195</volume>:<fpage>67</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201606-1306OC</pub-id><pub-id pub-id-type="pmid">27753501</pub-id></mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crimi</surname><given-names>C</given-names></name><name><surname>Noto</surname><given-names>A</given-names></name><name><surname>Princi</surname><given-names>P</given-names></name><name><surname>Esqunas</surname><given-names>A</given-names></name><name><surname>Nava</surname><given-names>S</given-names></name></person-group>. <article-title>A European Survey of noninvasive ventilation practices.</article-title> <source>Eur Respir J</source>. <year>2010</year>;<volume>36</volume>:<fpage>362</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00123509</pub-id><pub-id pub-id-type="pmid">20075052</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="preprint">ISARIC Clinical Characterisation Group. ISARIC COVID-19 Clinical Data Report issued 27 March 2022. [Internet]. Dostupno na: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.medrxiv.org/content/10.1101/2020.07.17.20155218v15">https://www.medrxiv.org/content/10.1101/2020.07.17.20155218v15</ext-link> [Pristupljeno 15. listopada 2022.].</mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Slutsky</surname><given-names>A</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name></person-group>. <article-title>Mechanical ventilation to minimize progression of lung injury in acute respiratory failure.</article-title> <source>Am J Respir Crit Care Med</source>. <year>2017</year>;<volume>195</volume>:<fpage>438</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201605-1081CP</pub-id><pub-id pub-id-type="pmid">27626833</pub-id></mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Marini</surname><given-names>JJ</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Quintel</surname><given-names>M</given-names></name><name><surname>Mancebo</surname><given-names>J</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name></person-group>. <article-title>The &#x201E;baby lung&#x201C; became an adult.</article-title> <source>Intensive Care Med</source>. <year>2016</year>;<volume>42</volume>:<fpage>663</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-015-4200-8</pub-id><pub-id pub-id-type="pmid">26781952</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauri</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Bellani</surname><given-names>G</given-names></name><name><surname>Goligher</surname><given-names>EC</given-names></name><name><surname>Carteaux</surname><given-names>G</given-names></name><name><surname>Rittayamai</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness and perspectives.</article-title> <source>Intensive Care Med</source>. <year>2016</year>;<volume>42</volume>:<fpage>1360</fpage>&#x2013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-016-4400-x</pub-id><pub-id pub-id-type="pmid">27334266</pub-id></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>M</given-names></name><name><surname>Mukao</surname><given-names>DS</given-names></name><name><surname>Russell</surname><given-names>JE</given-names></name><name><surname>Spiritus</surname><given-names>EM</given-names></name><name><surname>Wilson</surname><given-names>AF</given-names></name></person-group>. <article-title>A new method for measurement of airway occlusion pressure.</article-title> <source>Chest</source>. <year>1990</year>;<volume>98</volume>:<fpage>421</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1378/chest.98.2.421</pub-id><pub-id pub-id-type="pmid">2376174</pub-id></mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foti</surname><given-names>G</given-names></name><name><surname>Cereda</surname><given-names>M</given-names></name><name><surname>Banfi</surname><given-names>G</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name><name><surname>Fumagalli</surname><given-names>R</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name></person-group>. <article-title>End-inspiratory airway occlusion A method to assess the pressure developed by inspiratory muscles in patients with acute lung injury undergoing pressure support.</article-title> <source>Am J Respir Crit Care Med</source>. <year>1997</year>;<volume>156</volume>:<fpage>1210</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.156.4.96-02031</pub-id><pub-id pub-id-type="pmid">9351624</pub-id></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>MBP</given-names></name><name><surname>Meade</surname><given-names>MO</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Brochard</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>ELV</given-names></name><name><surname>Schoenfeld</surname><given-names>DA</given-names></name><etal/></person-group> <article-title>Driving pressure and survival in the acute respiratory distress syndrome.</article-title> <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>:<fpage>747</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsa1410639</pub-id><pub-id pub-id-type="pmid">25693014</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morais</surname><given-names>CC</given-names></name><name><surname>Koyama</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Plens</surname><given-names>GM</given-names></name><name><surname>Gomes</surname><given-names>S</given-names></name><name><surname>Lima</surname><given-names>CA</given-names></name><etal/></person-group> <article-title>High-positive end-expiratory pressure renders spontaneous effort noninjurious.</article-title> <source>Am J Respir Crit Care Med</source>. <year>2018</year>;<volume>197</volume>:<fpage>1285</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201706-1244OC</pub-id><pub-id pub-id-type="pmid">29323536</pub-id></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieillard-Baron</surname><given-names>A</given-names></name><name><surname>Rabiller</surname><given-names>A</given-names></name><name><surname>Chergui</surname><given-names>K</given-names></name><name><surname>Peyrouset</surname><given-names>O</given-names></name><name><surname>Page</surname><given-names>B</given-names></name><name><surname>Beauchet</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Prone position improves mechanics and alveolar ventilation in acute respiratory distress syndrome.</article-title> <source>Intensive Care Med</source>. <year>2005</year>;<volume>31</volume>:<fpage>220</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-004-2478-z</pub-id><pub-id pub-id-type="pmid">15703898</pub-id></mixed-citation></ref>
<ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koeckerling</surname><given-names>D</given-names></name><name><surname>Barker</surname><given-names>J</given-names></name><name><surname>Mudalige</surname><given-names>NI</given-names></name><name><surname>Oyefeso</surname><given-names>O</given-names></name><name><surname>Pan</surname><given-names>D</given-names></name><name><surname>Pareek</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Awake prone positioning in COVID-19.</article-title> <source>Thorax</source>. <year>2020</year>;<volume>75</volume>:<fpage>833</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2020-215133</pub-id><pub-id pub-id-type="pmid">32546571</pub-id></mixed-citation></ref>
<ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>BR</given-names></name><name><surname>Blakeman</surname><given-names>TC</given-names></name><name><surname>Toth</surname><given-names>P</given-names></name><name><surname>Haneman</surname><given-names>D</given-names></name><name><surname>Mueller</surname><given-names>E</given-names></name><name><surname>Branson</surname><given-names>RD</given-names></name></person-group>. <article-title>Patient-ventilator asynchrony in a traumatically injured population.</article-title> <source>Respir Care</source>. <year>2013</year>;<volume>58</volume>:<fpage>1847</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.4187/respcare.02237</pub-id><pub-id pub-id-type="pmid">23513248</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
